1. Acharya D. Predictors of outcomes in myocardial infarction and cardiogenic shock. Cardiol Rev 2018; 26: 255-266.
2.Arora G, Bittner V. Chest pain characteristics and gender in the early diagnosis of acute myocardial infarction. Curr Cardiol Rep 2015; 17: 5.
3. Sinclair D. Myocardial infarction. Considerations for geriatric patients. Can Fam Physician 1994; 40: 1172-1177.
4.Yang EH, Brilakis ES, Reeder GS, Gersh BJ. Modern management of acute myocardial infarction. Curr Probl Cardiol 2006; 31: 769-817.
5.Liu ZB, Fu XH, Wei G, Gao JL. Cytochrome c release in acute myocardial infarction predicts poor prognosis and myocardial reperfusion on contrast-enhanced magnetic resonance imaging. Coron Artery Dis 2014; 25: 66-72.
6.Mullasari AS, Balaji P, Khando T. Managing complications in acute myocardial infarction. J Assoc Physicians India 2011; 59 Suppl: 43-48.
7.Scroggins NM. Recognition and management of inferior wall myocardial infarctions and right ventricular infarcts. J Infus Nurs 2001; 24: 263-267.
8.Bounhoure JP, Ouldzen H, Carrie D, Alibelli MJ, Puel J. Myocardial infarction with "angiographically normal coronary arteries" myth or reality? Bull Acad Natl Med 2007; 191: 815-824; discussion 24-25.
9.Klem I, Kim RJ. Assessment of microvascular injury after acute myocardial infarction: the importance of the area at risk. Nat Clin Pract Cardiovasc Med 2008; 5: 756-757.
10.Hebsur S, Vakil E, Oetgen WJ, Kumar PN, Lazarous DF. Influenza and coronary artery disease: exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in the prevention of myocardial infarction. Rev Cardiovasc Med 2014; 15: 168-175.
11.Alpert JS, Thygesen KA, White HD, Jaffe AS. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med 2014; 127: 105-108.
12. Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course, and prognosis. J Am Coll Cardiol 1992; 20: 736-744.
13.Lee SI, Lee SY, Choi CH, Park KY, Park CH. Left heart decompression in acute complicated myocardial infarction during extracorporeal membrane oxygenation. J Intensive Care Med 2017; 32: 405-408.
14.Graf T, Desch S, Eitel I, Thiele H. Acute myocardial infarction and cardiogenic shock: pharmacologic and mechanical hemodynamic support pathways. Coron Artery Dis 2015; 26: 535-544.
15.Aymong ED, Ramanathan K, Buller CE. Pathophysiology of cardiogenic shock complicating acute myocardial infarction. Med Clin North Am 2007; 91: 701-712.
16.Norton M, Letizia M, Jennrich JA. Right ventricular infarction vs. left ventricular infarction: a review of pathophysiology, medical treatment, and nursing care. Medsurg Nurs 1993; 2: 203-209, 20.
17.Pollard TJ. The acute myocardial infarction. Primary care 2000; 27: 631-49; vi.
18. Bolognese L. Changing patterns of ST-elevation myocardial infarction epidemiology. Am Heart J 2010; 160: S1-S3.
19.Gupta T, Harikrishnan P, Kolte D, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, Jain D, Ahmed A, Lanier GM, Cooper HA, Frishman WH, Fonarow GC, Panza JA. Outcomes of acute myocardial infarction in patients with hypertrophic cardiomyopathy. Am J Med 2015; 128: 879-887 e1.
20. Tomcsanyi J, Tako K, Sharman B. Recurrent acute myocardial infarction as a thromboembolic complication of atrial fibrillation. Orv Hetil 2016; 157: 191-193.
21.Flapan AD. Management of patients after their first myocardial infarction. BMJ 1994; 309: 1129-1134.
22.Jariwala P, Chandra S. Diagnosis and management of failed thrombolytic therapy for acute myocardial infarction. Indian Heart J 2010; 62: 21-28.
23.Bovenzi F, De Luca L, de Luca I. Which is the best reperfusion strategy for patients with high-risk myocardial infarction? Ital Heart J 2004; 5 Suppl 6: 83S-91S.
24.Mintz E. Emergency department management of acute myocardial infarction. Mt Sinai J Med 1997; 64: 258-274.
25.Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, Robertson CL, Serova N, Davis S, Soboleva A. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res 2013; 41: D991-D995.
26.Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015; 43: e47.
27.Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinf 2008; 9: 559.
28.Yu G, Wang LG, Han Y, He QY. Cluster profiler: an R package for comparing biological themes among gene clusters. Omics: J integr Biol 2012; 16: 284-287.
29. Carlin DE, Demchak B, Pratt D, Sage E, Ideker T. Network propagation in the Cytoscape cyberinfrastructure. PLoS Comput Biol 2017; 13: e1005598.
30.Han H, Cho JW, Lee S, Yun A, Kim H, Bae D, Yang S, Kim CY, Lee M, Kim E, Lee S, Kang B, Jeong D, Kim Y, Jeon HN, Jung H, Nam S, Chung M, Kim JH, Lee I. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res 2018; 46: D380-D6.
31.Yi Y, Zhao Y, Li C, Zhang L, Huang H, Li Y, Liu L, Hou P, Cui T, Tan P, Hu Y, Zhang T, Huang Y, Li X, Yu J, Wang D. RAID v2.0: an updated resource of RNA-associated interactions across organisms. Nucleic Acids Res 2017; 45: D115-D118.
32.Kloner RA, Dai W, Hale SL, Shi J. Approaches to Improving cardiac structure and function during and after an acute myocardial infarction: acute and chronic phases. J Cardiovasc Pharmacol Ther 2016; 21: 363-367.
33.Grisel P, Roffi M, Muller H, Keller PF. Mechanical complications of myocardial infarction. Rev Med Suisse Romande 2011; 7: 1189-1192.
34.Silvain J, Collet JP, Guedeney P, Varenne O, Nagaswami C, Maupain C, Empana JP, Boulanger C, Tafflet M, Manzo-Silberman S, Kerneis M, Brugier D, Vignolles N, Weisel JW, Jouven X, Montalescot G, Spaulding C. Thrombus composition in sudden cardiac death from acute myocardial infarction. Resuscitation 2017; 113: 108-114.
35.Pasupathy S, Tavella R, Grover S, Raman B, Procter NEK, Du YT, Mahadavan G, Stafford I, Heresztyn T, Holmes A, Zeitz C, Arstall M, Selvanayagam J, Horowitz JD, Beltrame JF. Early use of N-acetylcysteine with nitrate therapy in patients undergoing primary percutaneous coronary intervention for ST-Segment-elevation myocardial infarction reduces myocardial infarct size (the NICAM Trial [N-acetylcysteine in Acute Myocardial Infarction]). Circulation 2017; 136: 894-903.
36.Yang H, Sun W, Quan N, Wang L, Chu D, Cates C, Liu Q, Zheng Y, Li J. Cardioprotective actions of Notch1 against myocardial infarction via LKB1-dependent AMPK signaling pathway. Biochem Pharmacol 2016; 108: 47-57.
37.Boccardi V, Rizzo MR, Marfella R, Papa M, Esposito A, Portoghese M, Paolisso G, Barbieri M. -94 ins/del ATTG NFKB1 gene variant is associated with lower susceptibility to myocardial infarction. Nutr Metab Cardiovasc Dis 2011; 21: 679-684.
38.Feng Y, Huang W, Wani M, Yu X, Ashraf M. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One 2014; 9: e88685.
39.Ding M, Lei J, Han H, Li W, Qu Y, Fu E, Wang X. SIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats. Cardiovasc Diabetol 2015; 14: 143.
40.Yang G, Weng X, Zhao Y, Zhang X, Hu Y, Dai X, Liang P, Wang P, Ma L, Sun X, Hou L, Xu H, Fang M, Li Y, Jenuwein T, Xu Y, Sun A. The histone H3K9 methyltransferase SUV39H links SIRT1 repression to myocardial infarction. Nat Commun 2017; 8: 14941.
41.Zhang D, Wang B, Ma M, Yu K, Zhang Q, Zhang X. LncRNA HOTAIR protects myocardial infarction rat by sponging miR-519d-3p. J Cardiovasc Transl Res 2019; 12:171-183.
42.Jiang N, Xia J, Jiang B, Xu Y, Li Y. TUG1 alleviates hypoxia injury by targeting miR-124 in H9c2 cells. Biomed Pharmacother 2018; 103: 1669-1677.
43.Liu J, Jiang M, Deng S, Lu J, Huang H, Zhang Y, Gong P, Shen X, Ruan H, Jin M, Wang H. MiR-93-5p-containing exosomes treatment attenuates acute myocardial infarction-induced myocardial damage. Mol Ther Nucleic Acids 2018; 11: 103-115.